Oglivose 0.2mg Tablet
Marketer
Orlife Healthcare
Salt Composition
Voglibose (0.2mg)
Overview Oglivose 0.2mg Tablet
Glimepiride 0.2mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated postprandial blood glucose. It's indicated when dietary modifications and other similar medications prove insufficient in controlling hyperglycemia. Administer Glimepiride 0.2mg just prior to meals. Dosage frequency is determined individually by your physician to optimize blood sugar control. Discontinue use only under your doctor's guidance; abrupt cessation may elevate blood glucose, increasing the risk of severe complications such as nephropathy and visual impairment. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, physical activity, and weight management as directed by your healthcare provider. Regular blood glucose monitoring is essential. Common adverse effects include bloating, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or bothersome side effects to your doctor. While Glimepiride itself rarely induces hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Glucose (dextrose) is the appropriate treatment for hypoglycemic episodes; sucrose is ineffective in this context. Inform your physician of any liver or kidney dysfunction before commencing treatment. Avoid Glimepiride if you have bowel inflammation (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals require medical consultation prior to use. Always disclose all medications to your doctor to ensure safe use. Excessive alcohol consumption should be avoided, as it can elevate the likelihood of hypoglycemia.
Primary Ingredients of Oglivose 0.2mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Oglivose 0.2mg Tablet
Managing Type 2 diabetes
Major Benefits of Oglivose 0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Oglivose 0.2mg Tablet should be administered on an empty stomach.
Common Side effects of Oglivose 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Oglivose 0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Oglivose 0.2mg Tablet should be administered on an empty stomach.
How Oglivose 0.2mg Tablet works:
Oglivose 0.2mg tablets are used to manage diabetes. They work by blocking intestinal enzymes that digest complex carbohydrates, thus preventing postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Oglivose 0.2mg tablets and alcohol is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Oglivose 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Taking Oglivose 0.2mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Oglivose 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Oglivose 0.2mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Oglivose 0.2mg tablets; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Oglivose 0.2mg Tablet :
Omit any missed Oglivose 0.2mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Oglivose 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
3,018 People bought this recently